Sarah Whelan, PhD
Science Writer
at Technology Networks
Sarah joined Technology Networks in 2022 after completing a PhD in cancer biology, where her research focused on the development of colon cancers. In her role as science writer and editor, Sarah covers scientific news and a range of other content types, leading the site's coverage of drug discovery, biopharma and cancer research content.
Education
Areas of Expertise
Got a Question for Sarah Whelan, PhD?
Get in touch using the contact form linked here and we’ll get back to you shortly
Published Content
Total: 296
News
No Evidence That CBD Products Reduce Chronic Pain, Study Finds
A new study has concluded that there is no evidence that cannabidiol (CBD) products reduce chronic pain, suggesting that they are not value for money and even have the potential to harm health.
Industry Insight
Setting the Stage for Multipurpose Drugs
We spoke with Dr. Bryan Oronsky, chief development officer at EpicentRx, to discover more about the promise of multipurpose drugs and the potential of EpicentRx’s nibrozetone (RRx-001) for several conditions.
News
Gene Editing Can Eliminate HIV From Cell Culture, Researchers Claim
The genome editing tool CRISPR-Cas9 can eliminate HIV viruses from lab-cultured cells, according to not-yet peer-reviewed research to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).
Listicle
Genetics in Disease
Some genetic diseases, like sickle cell anemia, are hereditary and present at birth. Others can be caused by spontaneous mutations, either arising from errors in DNA replication or exposure to environmental factors.
News
Metformin Tied to Production of “Anti-Hunger” Molecule
The same “anti-hunger” molecule stimulated by vigorous exercise can also be produced by the common diabetes drug metformin, according to a new study from Stanford University.
News
Could Genetics Influence Cancer Risk From Red and Processed Meats?
Researchers have explored whether genetics can influence the risk of colorectal cancer from the consumption of red and processed meat, identifying two genetic markers that may put some people at increased risk.
News
Alzheimer’s Drug Production a Step Closer With the Help of Bacteria and AI
Researchers have developed a microbial fermentation method to produce galantamine with the help of artificial intelligence (AI) and biosensors.
News
Genetic “Dark Matter” Could Help Monitor Cancer
Researchers from the Johns Hopkins Kimmel Cancer Center have developed a machine-learning approach that identifies these sequences in both tumor DNA and cell-free DNA (cfDNA) that are shed into the blood.
News
FDA To Delay Decision on New Alzheimer’s Drug Candidate
A candidate drug for Alzheimer’s disease, donanemab, will be further scrutinized by a US Food and Drug Administration (FDA) expert panel, drugmaker announces.
News
Vitamin A’s Role in Skin Influences Wound Repair and Hair Growth
Retinoic acid, a form of vitamin A, can regulate lineage plasticity in skin stem cells, suggests a new study that could have clinical implications for regenerative medicine, wound healing and even cancer.
Advertisement
